Rapamycin regulates biochemical metabolites

References

• Markert EK, Levine AJ, Vazquez A. Proliferation and tissue remodeling in cancer: the hallmarks revisited. Cell Death Dis 2012; 3:e397; http://dx.doi.org/10.1038/cddis.2012.140; PMID: 23034332
   PubMed Web of Science ®Google Scholar
• Lyssiotis CA, Vander-Heiden MG, Muñoz-Pinedo C, Emerling BM. Emerging concepts: linking hypoxic signaling and cancer metabolism. Cell Death Dis 2012; 3:e303; http://dx.doi.org/10.1038/cddis.2012.41; PMID: 22552280
   PubMedGoogle Scholar
• Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004; 6:91 - 9; http://dx.doi.org/10.1016/j.ccr.2004.06.007; PMID: 15261145
   PubMed Web of Science ®Google Scholar
• Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005; 37:19 - 24; http://dx.doi.org/10.1038/ng1494; PMID: 15624019
   PubMed Web of Science ®Google Scholar
• Inoki K, Guan KL. Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum Mol Genet 2009; 18:R1 R94 - 100; http://dx.doi.org/10.1093/hmg/ddp032; PMID: 19297407
   PubMedGoogle Scholar
• Sabatini DM. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 2006; 6:729 - 34; http://dx.doi.org/10.1038/nrc1974; PMID: 16915295
   PubMed Web of Science ®Google Scholar
• Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012; 485:109 - 13; http://dx.doi.org/10.1038/nature11083; PMID: 22552098
   PubMed Web of Science ®Google Scholar
• Shahbazian D, Parsyan A, Petroulakis E, Topisirovic I, Martineau Y, Gibbs BF, et al. Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B. Mol Cell Biol 2010; 30:1478 - 85; http://dx.doi.org/10.1128/MCB.01218-09; PMID: 20086100
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19:107 - 20; http://dx.doi.org/10.1038/cdd.2011.96; PMID: 21760595
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Melino G. The flick of a switch: which death program to choose?. Cell Death Differ 2012; 19:1093 - 5; http://dx.doi.org/10.1038/cdd.2012.65; PMID: 22684093
   PubMed Web of Science ®Google Scholar
• Marcel V, Dichtel-Danjoy ML, Sagne C, Hafsi H, Ma D, Ortiz-Cuaran S, et al. Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ 2011; 18:1815 - 24; http://dx.doi.org/10.1038/cdd.2011.120; PMID: 21941372
   PubMed Web of Science ®Google Scholar
• Marcel V, Petit I, Murray-Zmijewski F, Goullet de Rugy T, Fernandes K, Meuray V, et al. Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity. Cell Death Differ 2012; 19:816 - 26; http://dx.doi.org/10.1038/cdd.2011.152; PMID: 22075982
   PubMed Web of Science ®Google Scholar
• Nayak G, Cooper GM. p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase/Akt/GSK3 signaling. Cell Death Dis 2012; 3:e400; http://dx.doi.org/10.1038/cddis.2012.138; PMID: 23059819
   PubMed Web of Science ®Google Scholar
• Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical roles of p53. Oncogene 2013; http://dx.doi.org/10.1038/onc.2012.640; PMID: 23416979
   PubMed Web of Science ®Google Scholar
• Tucci P. Caloric restriction: is mammalian life extension linked to p53?. Aging (Albany NY) 2012; 4:525 - 34; PMID: 22983298
   PubMedGoogle Scholar
• Melino G. Journal club. A cancer biologist weighs up p53, metabolism and cancer. Nature 2010; 466:905; http://dx.doi.org/10.1038/466905d; PMID: 20725003
   PubMedGoogle Scholar
• Melino G. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 2011; 18:1487 - 99; http://dx.doi.org/10.1038/cdd.2011.81; PMID: 21760596
   PubMed Web of Science ®Google Scholar
• Shalom-Feuerstein R, Lena AM, Zhou H, De La Forest Divonne S, Van Bokhoven H, Candi E, et al. ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis. Cell Death Differ 2011; 18:887 - 96; http://dx.doi.org/10.1038/cdd.2010.159; PMID: 21127502
   PubMed Web of Science ®Google Scholar
• Ben-Sahra I, Dirat B, Laurent K, Puissant A, Auberger P, Budanov A, et al. Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death. Cell Death Differ 2013; 20:611 - 9; http://dx.doi.org/10.1038/cdd.2012.157; PMID: 23238567
   PubMed Web of Science ®Google Scholar
• Salah Z, Bar-mag T, Kohn Y, Pichiorri F, Palumbo T, Melino G, et al. Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapy. Cell Death Dis 2013; 4:e480; http://dx.doi.org/10.1038/cddis.2013.6; PMID: 23370280
   PubMed Web of Science ®Google Scholar
• Leonard MK, Kommagani R, Payal V, Mayo LD, Shamma HN, Kadakia MP. ΔNp63α regulates keratinocyte proliferation by controlling PTEN expression and localization. Cell Death Differ 2011; 18:1924 - 33; http://dx.doi.org/10.1038/cdd.2011.73; PMID: 21637289
   PubMed Web of Science ®Google Scholar
• Levine AJ, Tomasini R, McKeon FD, Mak TW, Melino G. The p53 family: guardians of maternal reproduction. Nat Rev Mol Cell Biol 2011; 12:259 - 65; http://dx.doi.org/10.1038/nrm3086; PMID: 21427767
   PubMed Web of Science ®Google Scholar
• Tomasini R, Mak TW, Melino G. The impact of p53 and p73 on aneuploidy and cancer. Trends Cell Biol 2008; 18:244 - 52; http://dx.doi.org/10.1016/j.tcb.2008.03.003; PMID: 18406616
   PubMed Web of Science ®Google Scholar
• Notari M, Hu Y, Koch S, Lu M, Ratnayaka I, Zhong S, et al. Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification. Proc Natl Acad Sci U S A 2011; 108:16645 - 50; http://dx.doi.org/10.1073/pnas.1102292108; PMID: 21930934
   PubMed Web of Science ®Google Scholar
• Candi E, Rufini A, Terrinoni A, Giamboi-Miraglia A, Lena AM, Mantovani R, et al. DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc Natl Acad Sci U S A 2007; 104:11999 - 2004; http://dx.doi.org/10.1073/pnas.0703458104; PMID: 17626181
   PubMed Web of Science ®Google Scholar
• Rivetti di Val Cervo P, Lena AM, Nicoloso M, Rossi S, Mancini M, Zhou H, et al. p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci U S A 2012; 109:1133 - 8; http://dx.doi.org/10.1073/pnas.1112257109; PMID: 22228303
   PubMed Web of Science ®Google Scholar
• Tucci P, Agostini M, Grespi F, Markert EK, Terrinoni A, Vousden KH, et al. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci U S A 2012; 109:15312 - 7; http://dx.doi.org/10.1073/pnas.1110977109; PMID: 22949650
   PubMed Web of Science ®Google Scholar
• Müller M, Schilling T, Sayan AE, Kairat A, Lorenz K, Schulze-Bergkamen H, et al. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ 2005; 12:1564 - 77; http://dx.doi.org/10.1038/sj.cdd.4401774; PMID: 16195739
   PubMed Web of Science ®Google Scholar
• Wang J, Liu YX, Hande MP, Wong AC, Jin YJ, Yin Y. TAp73 is a downstream target of p53 in controlling the cellular defense against stress. J Biol Chem 2007; 282:29152 - 62; http://dx.doi.org/10.1074/jbc.M703408200; PMID: 17693405
   PubMed Web of Science ®Google Scholar
• Grob TJ, Novak U, Maisse C, Barcaroli D, Lüthi AU, Pirnia F, et al. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 2001; 8:1213 - 23; http://dx.doi.org/10.1038/sj.cdd.4400962; PMID: 11753569
   PubMed Web of Science ®Google Scholar
• Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG Jr., Levrero M, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999; 399:806 - 9; http://dx.doi.org/10.1038/21690; PMID: 10391249
   PubMed Web of Science ®Google Scholar
• Rossi M, De Laurenzi V, Munarriz E, Green DR, Liu Y-C, Vousden KH, et al. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J 2005; 24:836 - 48; http://dx.doi.org/10.1038/sj.emboj.7600444; PMID: 15678106
   PubMed Web of Science ®Google Scholar
• Rossi M, Aqeilan RI, Neale M, Candi E, Salomoni P, Knight RA, et al. The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc Natl Acad Sci U S A 2006; 103:12753 - 8; http://dx.doi.org/10.1073/pnas.0603449103; PMID: 16908849
   PubMed Web of Science ®Google Scholar
• Peschiaroli A, Scialpi F, Bernassola F, Pagano M, Melino G. The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73. Oncogene 2009; 28:3157 - 66; http://dx.doi.org/10.1038/onc.2009.177; PMID: 19581926
   PubMed Web of Science ®Google Scholar
• Dulloo I, Gopolan G, Melino G, Sabapathy S. The DeltaNp73 oncogene is degraded in a c-Jun-dependent manner upon genotoxic stress through the antizyme-mediated pathway. Proc Natl Acad Sci USA 2010; 107:4902 - 7; http://dx.doi.org/10.1073/pnas.0906782107; PMID: 20185758
   PubMed Web of Science ®Google Scholar
• Sayan BS, Yang AL, Conforti F, Tucci P, Piro MC, Browne GJ, et al. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2. Proc Natl Acad Sci U S A 2010; 107:12877 - 82; http://dx.doi.org/10.1073/pnas.0911828107; PMID: 20615966
   PubMed Web of Science ®Google Scholar
• Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008; 22:2677 - 91; http://dx.doi.org/10.1101/gad.1695308; PMID: 18805989
   PubMed Web of Science ®Google Scholar
• Rufini A, Niklison-Chirou MV, Inoue S, Tomasini R, Harris IS, Marino A, et al. TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev 2012; 26:2009 - 14; http://dx.doi.org/10.1101/gad.197640.112; PMID: 22987635
   PubMed Web of Science ®Google Scholar
• Wilhelm MT, Rufini A, Wetzel MK, Tsuchihara K, Inoue S, Tomasini R, et al. Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes Dev 2010; 24:549 - 60; http://dx.doi.org/10.1101/gad.1873910; PMID: 20194434
   PubMed Web of Science ®Google Scholar
• Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000; 404:99 - 103; http://dx.doi.org/10.1038/35003607; PMID: 10716451
   PubMed Web of Science ®Google Scholar
• Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 2000; 289:304 - 6; http://dx.doi.org/10.1126/science.289.5477.304; PMID: 10894779
   PubMed Web of Science ®Google Scholar
• Billon N, Terrinoni A, Jolicoeur C, McCarthy A, Richardson WD, Melino G, et al. Roles for p53 and p73 during oligodendrocyte development. Development 2004; 131:1211 - 20; http://dx.doi.org/10.1242/dev.01035; PMID: 14960496
   PubMed Web of Science ®Google Scholar
• Agostini M, Tucci P, Killick R, Candi E, Sayan BS, Rivetti di Val Cervo P, et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci U S A 2011; 108:21093 - 8; http://dx.doi.org/10.1073/pnas.1112061109; PMID: 22160687
   PubMed Web of Science ®Google Scholar
• Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D, et al. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci U S A 2011; 108:21099 - 104; http://dx.doi.org/10.1073/pnas.1112063108; PMID: 22160706
   PubMed Web of Science ®Google Scholar
• Tomasini R, Tsuchihara K, Tsuda C, Lau SK, Wilhelm M, Ruffini A, et al. TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity. Proc Natl Acad Sci U S A 2009; 106:797 - 802; http://dx.doi.org/10.1073/pnas.0812096106; PMID: 19139399
   PubMed Web of Science ®Google Scholar
• Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer 2004; 4:335 - 48; http://dx.doi.org/10.1038/nrc1362; PMID: 15122205
   PubMed Web of Science ®Google Scholar
• Tucci P, Porta G, Agostini M, Dinsdale D, Iavicoli I, Cain K, et al. Metabolic effects of TiO2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes. Cell Death Dis 2013; 4e:549; http://dx.doi.org/10.1038/cddis.2013.76; PMID: 23519118
   PubMed Web of Science ®Google Scholar
• Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471 - 84; http://dx.doi.org/10.1016/j.cell.2006.01.016; PMID: 16469695
   PubMed Web of Science ®Google Scholar
• Hands SL, Proud CG, Wyttenbach A. mTOR’s role in ageing: protein synthesis or autophagy?. Aging (Albany NY) 2009; 1:586 - 97; PMID: 20157541
   PubMedGoogle Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27 - 42; http://dx.doi.org/10.1016/j.cell.2007.12.018; PMID: 18191218
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451:1069 - 75; http://dx.doi.org/10.1038/nature06639; PMID: 18305538
   PubMed Web of Science ®Google Scholar
• Newbold A, Vervoort SJ, Martin BP, Bots M, Johnstone RW. Induction of autophagy does not alter the anti-tumor effects of HDAC inhibitors. Cell Death Dis 2012; 3:e387; http://dx.doi.org/10.1038/cddis.2012.128; PMID: 22951984
   PubMedGoogle Scholar
• Melino G, Knight RA, Nicotera P. How many ways to die? How many different models of cell death?. Cell Death Differ 2005; 12:Suppl 2 1457 - 62; http://dx.doi.org/10.1038/sj.cdd.4401781; PMID: 16247490
   PubMed Web of Science ®Google Scholar
• Rosenbluth JM, Mays DJ, Pino MF, Tang LJ, Pietenpol JA. A gene signature-based approach identifies mTOR as a regulator of p73. Mol Cell Biol 2008; 28:5951 - 64; http://dx.doi.org/10.1128/MCB.00305-08; PMID: 18678646
   PubMed Web of Science ®Google Scholar
• Rosenbluth JM, Mays DJ, Jiang A, Shyr Y, Pietenpol JA. Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis. Proc Natl Acad Sci U S A 2011; 108:2076 - 81; http://dx.doi.org/10.1073/pnas.1011936108; PMID: 21245298
   PubMed Web of Science ®Google Scholar
• Hu W, Zhang C, Wu R, Sun Y, Levine AJ, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A 2010; 107:7455 - 60; http://dx.doi.org/10.1073/pnas.1001006107; PMID: 20378837
   PubMed Web of Science ®Google Scholar
• Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A 2010; 107:7461 - 6; http://dx.doi.org/10.1073/pnas.1002459107; PMID: 20351271
   PubMed Web of Science ®Google Scholar
• Ye J, Mancuso A, Tong X, Ward PS, Fan J, Rabinowitz JD, et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A 2012; 109:6904 - 9; http://dx.doi.org/10.1073/pnas.1204176109; PMID: 22509023
   PubMed Web of Science ®Google Scholar
• Maddocks ODK, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 2013; 493:542 - 6; http://dx.doi.org/10.1038/nature11743; PMID: 23242140
   PubMed Web of Science ®Google Scholar
• Leontieva OV, Gudkov AV, Blagosklonny MV. Weak p53 permits senescence during cell cycle arrest. Cell Cycle 2010; 9:4323 - 7; http://dx.doi.org/10.4161/cc.9.21.13584; PMID: 21051933
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344 - 52; PMID: 20606252
   PubMedGoogle Scholar
• Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci U S A 2010; 107:9660 - 4; http://dx.doi.org/10.1073/pnas.1002298107; PMID: 20457898
   PubMed Web of Science ®Google Scholar